Alessandra Gennari
- Oncology top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 5%
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Matteo PuntoniPierfranco ContéAndrea DeCensiPaolo BruzziBernardo BonanniMassimiliano CazzanigaSara GandiniPamela J. Goodwin
- Topics
- Cancer Treatment and Pharmacology (56 papers)Breast Cancer Treatment Studies (32 papers)HER2/EGFR in Cancer Research (22 papers)
- Journals
- CirculationJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Alessandra Gennari
153 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 2.4k
- Molecular Biology 1.5k
- Cancer Research 1.2k
- Pulmonary and Respiratory Medicine 773
- Cardiology and Cardiovascular Medicine 687
Countries citing papers authored by Alessandra Gennari
This map shows the geographic impact of Alessandra Gennari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Gennari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Gennari more than expected).
Fields of papers citing papers by Alessandra Gennari
This network shows the impact of papers produced by Alessandra Gennari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Gennari. The network helps show where Alessandra Gennari may publish in the future.
Co-authorship network of co-authors of Alessandra Gennari
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Gennari. A scholar is included among the top collaborators of Alessandra Gennari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Gennari. Alessandra Gennari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 16 | |
| 3 | 6 | |
| 4 | 32 | |
| 5 | 1 | |
| 6 | 34 | |
| 7 | 20 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 34 | |
| 11 | 3 | |
| 12 | 40 | |
| 13 | 195 | |
| 14 | Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysisbreakdown → | 713 |
| 15 | 9 | |
| 16 | 258 | |
| 17 | 29 | |
| 18 | 47 | |
| 19 | Epirubicin/taxane combinations in breast cancer: experience from several Italian trials. | 3 |
| 20 | New combinations with epirubicin in advanced breast cancer. | 3 |
About Alessandra Gennari
Alessandra Gennari is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 164 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (56 papers), Breast Cancer Treatment Studies (32 papers) and HER2/EGFR in Cancer Research (22 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.2k citations) and Cardiology and Cardiovascular Medicine (687 citations). Alessandra Gennari has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Matteo Puntoni, Pierfranco Conté, Andrea DeCensi, Paolo Bruzzi, Bernardo Bonanni, Massimiliano Cazzaniga, Sara Gandini, Pamela J. Goodwin, Cinzia Orlandini and Paola Mattei. Their work appears in journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.